Cite Filings / CLDI / 0001172661-25-003581

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Calidi Biotherapeutics, Inc. Filed 2025-08-14 Acc 0001172661-25-003581

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-02-10 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-19 CORRESP Correspondence Between Filers and SEC Staff
2025-08-19 CORRESP Correspondence Between Filers and SEC Staff
2025-08-15 S-1 Registration Statement
2025-08-14 8-K Material agreement · Executive or director change
2025-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
2025-08-08 10-Q Quarterly Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…